This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Kotobuki Pharmaceutical Co Ltd, National Cancer Center. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 424 
1 out of 27 
1 out of 263 
Years Active: 2016-2020
Title: The Innovative Mind of Makoto Asaumi: A Beacon in Cancer Research.
Introduction
Makoto Asaumi, a prolific inventor based in Tokyo, Japan, has made significant contributions to the field of cancer research through his innovative inventions. With a total of four patents to his name, Asaumi’s work focuses on elucidating genetic factors that play a role in cancer, highlighting the intersection of biotechnology and medical research.
Latest Patents
Asaumi's latest patents delve into groundbreaking methods for detecting specific genes associated with cancer. One prominent patent describes a method for detecting the OCLN-ARHGAP26 gene, which aims to identify a new causative gene for cancer. This invention encompasses a polynucleotide detection method and provides a primer set designed for accurate gene identification. It facilitates the detection of a fusion gene derived from parts of the OCLN and ARHGAP26 genes, enabling more precise diagnostics in oncology.
Another significant patent focuses on methods for treating cancer by inhibiting the FGFR3/TACC3 fusion protein. This invention not only identifies a novel responsible gene for cancer but also presents a comprehensive method for detecting the associated polynucleotide and polypeptide. It includes the development of a detection kit and pharmaceutical compositions for cancer treatment, offering hope for new therapies that target specific cancer-related genes and proteins.
Career Highlights
Throughout his career, Makoto Asaumi has contributed to esteemed organizations such as Astellas Pharma and the National Cancer Center. His work at Astellas Pharma is particularly notable for its focus on innovative pharmaceutical solutions to address critical health issues, making a positive impact in the field of oncology.
Collaborations
Asaumi’s journey has been enriched by collaborations with notable colleagues, including Kazuhisa Tsunoyama and Atsushi Suzuki. These partnerships have facilitated knowledge exchange and collective advancements in cancer research, allowing for interdisciplinary approaches to solving complex medical challenges.
Conclusion
Makoto Asaumi stands out as an influential inventor in the realm of cancer research. His patents not only pave the way for improved detection methods but also offer substantial promise for future cancer treatments. Through his dedication and innovative spirit, Asaumi continues to contribute significantly to medical science, embodying the potential of inventions to transform lives and enhance health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile